Material Insights · Understanding the Material World

Stent: Evolution

Timeline

The milestones of the product, each with a source

YearEvent
1977Andreas Gruntzig performs the first percutaneous coronary intervention, with a balloon, in September [2]
1986Jacques Puel, in France, and Ulrich Sigwart introduce metallic coronary stents into clinical practice; Puel's first stent goes in in March [2][8]
1993The FDA approves Cook's Gianturco-Roubin coronary stent, already marketed in Australia, Korea and Singapore [6][22]
1994The FDA approves the Palmaz-Schatz stent and J&J launches it in the United States [8][7]
1999The first drug-eluting stent is implanted [7]
2003The Cypher is the first drug-eluting stent approved by the FDA [8]
2011Abbott's Absorb bioresorbable scaffold receives a CE mark in January [7]
2016The FDA approves the Absorb in July [7]
2017India's NPPA caps coronary stent prices under notification S.O. 412(E) of 13 February [11]

as of 2026-11-13

Lineage

The products and technologies it evolved from and into

Evolved from
  • Stn Coronary stent The twin technology page holds the working principle and history; this node covers the stent as goods.

as of 2026-11-13

Recipe changes

How what it is made of changed over time, and what drove each change

ChangeFromToDriverSource
Metal platform and strut thicknessStainless steel with struts of 130 to 150 µmCobalt-chromium and platinum-chromium alloys with struts of 50 to 90 µmThinner struts reduced vascular damage while keeping radial strength [6][2][6][2]
Drug coatingDurable polymer carriersBiodegradable polymer coatings made from lactic or glycolic acids, which dissolve once the drug is released, in some designsThe sources opened name no single reason [2][2]
Bare metal to drug-elutingBare metal stentsDrug-eluting stents, which at first shared the stainless-steel backbone of bare metal ones (approved in the early 2000s)A drug on the stent to deal with re-narrowing [5][5]
Permanent metal to dissolving scaffoldPermanent metal stentsBioresorbable scaffolds such as the Absorb, with thick struts (150 µm against 81 µm for the Xience)Scaffold made to dissolve; development was reported to have failed to achieve further clinical benefits [6][5][6][5]

as of 2026-11-13

What could improve it next

Directions for improvement, today's value and the limit

DirectionMetricTodayUnitSource
Thinner struts in drug-eluting stentsStrut thickness of the Xience cobalt-chromium stent81µm[6]
Zinc and magnesium dissolving scaffolds under studyStrut thickness of the Absorb scaffold, the dissolving design to improve on150µm[6][5]

as of 2026-11-13

Sources

  1. State of the art: coronary artery stents – past, present and future EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
  2. Modern Stents: Where Are We Going? Rambam Maimonides Medical Journal (Kobo and others), 2020, RMMJ 2020;11(2):e0017, DOI 10.5041/RMMJ.10403
  3. Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry REC: Interventional Cardiology 6(4):321-331 (Macaya-Ten, Gonzalo, Escaned, Macaya), 2024
  4. The Surprising History Behind an Extremely Common Cardiovascular Medical Device MD+DI, no byline or date shown on the page
  5. Stents at 25 years: A revolution in revascularization Healio (Cardiology Today, Brian Ellis), 2011, dated April 01, 2011
  6. Lok Sabha Unstarred Question No. 2781, Guidelines by NPPA, answered 13 March 2018 Lok Sabha, Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), 2018
  7. Cook's Gianturco-Roubin Flex-Stent is first coronary stent approved by FDA (title from the page address; the page text shows no headline) The Gray Sheet, on Medtech Insight (Informa), no date shown; the text gives the FDA panel of May 1992 and approval on 'May 28', which REC (2024) places in 1993